Hematology Analyzers and Reagents Market Outlook 2028 | Revenue Models
The Global Hematology Analyzers and Reagents Market is expected to reach at high CAGR of 5.6% by 2028 | DataM Intelligence
(EMAILWIRE.COM, August 31, 2021 ) Market Overview
Hematology involves the science or investigation of blood cells and coagulation. Blood testing is essential for the usual physiological symptoms, such as infections, anemia, autoimmune disorders, diabetes, and cancer. Blood analysis or examination often reveals genetic data, organ defects, viruses, and so on. Hematology analyzers are commonly available to analyze blood and blood-related issues and take the form of simple handheld photo-optical equipment, advanced diagnostic point-of-care tools, and a highly automated or complex test facility analyzer.
Market Dynamics
The rates for automated hematology Instruments coupled with the preferences for high-sensitivity point-of-care (POC) hematology tests are expected to drive the market for hematology analyzers and reagents during the forecast period. In addition, rapid technological advances such as the implementation of basic flow cytometry techniques and the growth of high throughput hematology analyzers are expected to have a high impact on this industry's drivers.
Technological Advancements in Hematology Analyzers
The players active in the hematology analyzers and reagents market are highly competitive and have introduced novel products and reagents in the past. For instance, in May 2020, Beckman Coulter introduced DxH 690T hematology analyzer in the US to streamline workflow and reduce downtime in medium-sized laboratories. Besides, in August 2020, IDEXX Laboratories, Inc. launched a ProCyte OneHematology Analyzer to help deliver workflows with ease and accuracy at the point of treatment. The company also confirmed plans for the global roll-out of this product by early 2021. Besides, Sysmex unveiled an automated XN-L hematology analyzer in the US in July 2017. Later in September 2018, XS-500ix was also released on the Chinese market; the latest device is an automated hematology analyzer of the XS series. Also, Agappe Diagnostics, in partnership with L&T Technology Services Limited, launched the first indigenous hematology analyzer, Mispa Count X, in September 2020. The introduction of such new products is fuelling the growth of the market for hematology analyzers and reagents.
Lack of preference
The lack of preference, which results in a slow rate of adoption of this instrument from developing regions of the world, is a limiting factor for market development. Increased customer fears about these products' safety and efficacy in the context of recent recall by major market players.
Segmentation Analysis
By Product & Service
• Hematology Products and Services
• Hemostasis Products and Instruments
• Immunohematology Products and Services
By Application
• Anemia
• Blood Cancer
• Hemorrhagic Conditions
By End User
• Hospital Laboratories
• Commercial Service Providers
Geographical Analysis
Based on geography, the study analyzes the hematology analyzers and reagents market in the global market, including North America, Europe, Asia-Pacific, South America, and the Middle East & Africa.
North America is expected to dominate the global hematology analyzers and reagents market
North America is held a dominant position in the global hematology analyzers and reagents market in 2019. In North America, the U.S. is expected to represent considerable growth during the forecast period. Factors attributed to the region's development include the rising incidence of patients suffering from blood disorders, the growing prevalence of target diseases, and the increasing demand for blood transfusions. Moreover, Latin America is expected to represent significant growth in terms of value during the forecast period. Growing adoption rates towards automated hematology instruments coupled with increasing preferences towards high sensitivity point-of-care (POC) hematology testing is a factor behind region growth. Additionally, the hematology analyzers and reagents market for Asia Pacific is expected to observe rapid growth over the forecast period, backed by the increasing incidence of hematologic diseases and technological advancement.
Competitive Landscape
The hematology analyzers and reagents market is highly competitive. The key hematology analyzer and reagent players which are contributing to the growth of the global market include Clinical Diagnostic Solutions, Inc., Shenzhen Mindray Bio-Medical Electronics Co., Ltd., Danaher, Bio-Rad Laboratories Inc., Abbott Laboratories, Diatron, ERBA Diagnostics Inc., EKF Diagnostics HORIBA Medical, Biosystems S.A., among others. The major players are adopting new product launch and expansion strategies for global growth in the hematology analyzers and reagents market.
Related Topic's
DNA and RNA Extraction Kit Market, Biological Safety Testing Market, Herbal Supplements Market, Melatonin Market, Real-World Evidence Solutions Market
Hematology involves the science or investigation of blood cells and coagulation. Blood testing is essential for the usual physiological symptoms, such as infections, anemia, autoimmune disorders, diabetes, and cancer. Blood analysis or examination often reveals genetic data, organ defects, viruses, and so on. Hematology analyzers are commonly available to analyze blood and blood-related issues and take the form of simple handheld photo-optical equipment, advanced diagnostic point-of-care tools, and a highly automated or complex test facility analyzer.
Market Dynamics
The rates for automated hematology Instruments coupled with the preferences for high-sensitivity point-of-care (POC) hematology tests are expected to drive the market for hematology analyzers and reagents during the forecast period. In addition, rapid technological advances such as the implementation of basic flow cytometry techniques and the growth of high throughput hematology analyzers are expected to have a high impact on this industry's drivers.
Technological Advancements in Hematology Analyzers
The players active in the hematology analyzers and reagents market are highly competitive and have introduced novel products and reagents in the past. For instance, in May 2020, Beckman Coulter introduced DxH 690T hematology analyzer in the US to streamline workflow and reduce downtime in medium-sized laboratories. Besides, in August 2020, IDEXX Laboratories, Inc. launched a ProCyte OneHematology Analyzer to help deliver workflows with ease and accuracy at the point of treatment. The company also confirmed plans for the global roll-out of this product by early 2021. Besides, Sysmex unveiled an automated XN-L hematology analyzer in the US in July 2017. Later in September 2018, XS-500ix was also released on the Chinese market; the latest device is an automated hematology analyzer of the XS series. Also, Agappe Diagnostics, in partnership with L&T Technology Services Limited, launched the first indigenous hematology analyzer, Mispa Count X, in September 2020. The introduction of such new products is fuelling the growth of the market for hematology analyzers and reagents.
Lack of preference
The lack of preference, which results in a slow rate of adoption of this instrument from developing regions of the world, is a limiting factor for market development. Increased customer fears about these products' safety and efficacy in the context of recent recall by major market players.
Segmentation Analysis
By Product & Service
• Hematology Products and Services
• Hemostasis Products and Instruments
• Immunohematology Products and Services
By Application
• Anemia
• Blood Cancer
• Hemorrhagic Conditions
By End User
• Hospital Laboratories
• Commercial Service Providers
Geographical Analysis
Based on geography, the study analyzes the hematology analyzers and reagents market in the global market, including North America, Europe, Asia-Pacific, South America, and the Middle East & Africa.
North America is expected to dominate the global hematology analyzers and reagents market
North America is held a dominant position in the global hematology analyzers and reagents market in 2019. In North America, the U.S. is expected to represent considerable growth during the forecast period. Factors attributed to the region's development include the rising incidence of patients suffering from blood disorders, the growing prevalence of target diseases, and the increasing demand for blood transfusions. Moreover, Latin America is expected to represent significant growth in terms of value during the forecast period. Growing adoption rates towards automated hematology instruments coupled with increasing preferences towards high sensitivity point-of-care (POC) hematology testing is a factor behind region growth. Additionally, the hematology analyzers and reagents market for Asia Pacific is expected to observe rapid growth over the forecast period, backed by the increasing incidence of hematologic diseases and technological advancement.
Competitive Landscape
The hematology analyzers and reagents market is highly competitive. The key hematology analyzer and reagent players which are contributing to the growth of the global market include Clinical Diagnostic Solutions, Inc., Shenzhen Mindray Bio-Medical Electronics Co., Ltd., Danaher, Bio-Rad Laboratories Inc., Abbott Laboratories, Diatron, ERBA Diagnostics Inc., EKF Diagnostics HORIBA Medical, Biosystems S.A., among others. The major players are adopting new product launch and expansion strategies for global growth in the hematology analyzers and reagents market.
Related Topic's
DNA and RNA Extraction Kit Market, Biological Safety Testing Market, Herbal Supplements Market, Melatonin Market, Real-World Evidence Solutions Market
Contact Information:
DataM Intelligence
Sai Kiran
Tel: +1 877 441 4866
Email us
----
This press release is posted on EmailWire.com -- a global newswire that provides Press Release Distribution Services with Guaranteed Results
DataM Intelligence
Sai Kiran
Tel: +1 877 441 4866
Email us
----
This press release is posted on EmailWire.com -- a global newswire that provides Press Release Distribution Services with Guaranteed Results